RenovoRx Net Income vs Other Operating Expenses Analysis

RNXT Stock  USD 1.04  0.01  0.97%   
RenovoRx financial indicator trend analysis is much more than just breaking down RenovoRx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RenovoRx is a good investment. Please check the relationship between RenovoRx Net Income and its Other Operating Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

Net Income vs Other Operating Expenses

Net Income vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RenovoRx Net Income account and Other Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between RenovoRx's Net Income and Other Operating Expenses is -0.92. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of RenovoRx, assuming nothing else is changed. The correlation between historical values of RenovoRx's Net Income and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of RenovoRx are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Income i.e., RenovoRx's Net Income and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.92
Relationship DirectionNegative 
Relationship StrengthSignificant

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in RenovoRx financial statement analysis. It represents the amount of money remaining after all of RenovoRx operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RenovoRx. It is also known as RenovoRx overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from RenovoRx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 44.5 M in 2025, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2025.
 2021 2024 2025 (projected)
Depreciation And Amortization9K5.4K5.1K
Interest Income57K127.7K64.4K

RenovoRx fundamental ratios Correlations

-0.36-0.01-0.080.860.55-0.74-0.090.031.0-0.22-0.06-0.481.00.17-0.11-0.570.860.44-0.590.861.00.170.980.170.17
-0.36-0.82-0.49-0.66-0.820.90.850.24-0.34-0.63-0.750.87-0.340.48-0.650.85-0.68-0.850.76-0.7-0.370.48-0.240.480.48
-0.01-0.820.870.160.35-0.56-0.57-0.65-0.030.450.5-0.44-0.03-0.360.46-0.410.220.45-0.260.23-0.01-0.36-0.2-0.36-0.36
-0.08-0.490.87-0.15-0.09-0.27-0.11-0.93-0.080.040.040.0-0.08-0.050.020.01-0.050.00.17-0.06-0.08-0.05-0.29-0.05-0.05
0.86-0.660.16-0.150.89-0.9-0.570.250.840.230.45-0.850.84-0.170.32-0.90.980.82-0.921.00.86-0.170.85-0.17-0.17
0.55-0.820.35-0.090.89-0.88-0.860.310.530.650.78-0.980.53-0.50.68-0.980.850.96-0.980.880.55-0.50.54-0.5-0.5
-0.740.9-0.56-0.27-0.9-0.880.690.1-0.72-0.37-0.550.88-0.720.28-0.440.92-0.91-0.860.86-0.93-0.740.28-0.650.280.28
-0.090.85-0.57-0.11-0.57-0.860.69-0.19-0.07-0.87-0.960.91-0.070.63-0.840.85-0.53-0.90.81-0.57-0.090.63-0.060.630.63
0.030.24-0.65-0.930.250.310.1-0.190.020.260.26-0.240.02-0.130.34-0.240.120.29-0.380.170.03-0.130.22-0.13-0.13
1.0-0.34-0.03-0.080.840.53-0.72-0.070.02-0.24-0.09-0.451.00.18-0.13-0.550.850.42-0.570.851.00.180.980.180.18
-0.22-0.630.450.040.230.65-0.37-0.870.26-0.240.85-0.66-0.24-0.80.91-0.560.180.67-0.530.23-0.22-0.8-0.23-0.8-0.8
-0.06-0.750.50.040.450.78-0.55-0.960.26-0.090.85-0.83-0.09-0.690.84-0.770.440.83-0.750.45-0.06-0.69-0.07-0.69-0.69
-0.480.87-0.440.0-0.85-0.980.880.91-0.24-0.45-0.66-0.83-0.450.46-0.70.99-0.81-0.980.97-0.85-0.480.46-0.450.460.46
1.0-0.34-0.03-0.080.840.53-0.72-0.070.021.0-0.24-0.09-0.450.18-0.13-0.550.850.42-0.570.851.00.180.980.180.18
0.170.48-0.36-0.05-0.17-0.50.280.63-0.130.18-0.8-0.690.460.18-0.640.39-0.24-0.410.37-0.170.171.00.181.01.0
-0.11-0.650.460.020.320.68-0.44-0.840.34-0.130.910.84-0.7-0.13-0.64-0.640.240.78-0.610.32-0.11-0.64-0.12-0.64-0.64
-0.570.85-0.410.01-0.9-0.980.920.85-0.24-0.55-0.56-0.770.99-0.550.39-0.64-0.87-0.980.99-0.91-0.580.39-0.550.390.39
0.86-0.680.22-0.050.980.85-0.91-0.530.120.850.180.44-0.810.85-0.240.24-0.870.76-0.880.980.86-0.240.84-0.24-0.24
0.44-0.850.450.00.820.96-0.86-0.90.290.420.670.83-0.980.42-0.410.78-0.980.76-0.960.820.45-0.410.42-0.41-0.41
-0.590.76-0.260.17-0.92-0.980.860.81-0.38-0.57-0.53-0.750.97-0.570.37-0.610.99-0.88-0.96-0.91-0.590.37-0.60.370.37
0.86-0.70.23-0.061.00.88-0.93-0.570.170.850.230.45-0.850.85-0.170.32-0.910.980.82-0.910.86-0.170.84-0.17-0.17
1.0-0.37-0.01-0.080.860.55-0.74-0.090.031.0-0.22-0.06-0.481.00.17-0.11-0.580.860.45-0.590.860.170.980.170.17
0.170.48-0.36-0.05-0.17-0.50.280.63-0.130.18-0.8-0.690.460.181.0-0.640.39-0.24-0.410.37-0.170.170.181.01.0
0.98-0.24-0.2-0.290.850.54-0.65-0.060.220.98-0.23-0.07-0.450.980.18-0.12-0.550.840.42-0.60.840.980.180.180.18
0.170.48-0.36-0.05-0.17-0.50.280.63-0.130.18-0.8-0.690.460.181.0-0.640.39-0.24-0.410.37-0.170.171.00.181.0
0.170.48-0.36-0.05-0.17-0.50.280.63-0.130.18-0.8-0.690.460.181.0-0.640.39-0.24-0.410.37-0.170.171.00.181.0
Click cells to compare fundamentals

RenovoRx Account Relationship Matchups

RenovoRx fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets1.9M16.3M7.3M1.5M1.7M1.6M
Other Current Liab1.2M413K568K614K706.1K666.4K
Total Current Liabilities4.1M938K1.1M1.2M1.1M1.3M
Total Stockholder Equity(14.7M)15.3M6.2M(3M)(3.5M)(3.3M)
Net Debt995K(15.2M)(6.4M)(1.2M)(1.1M)(1.1M)
Retained Earnings(15.0M)(21.3M)(31.2M)(41.4M)(37.3M)(39.1M)
Accounts Payable162K525K534K561K645.2K510.4K
Cash1.8M15.2M6.4M1.2M1.3M1.3M
Cash And Short Term Investments1.8M15.2M6.4M1.2M1.3M1.3M
Liabilities And Stockholders Equity1.9M16.3M7.3M1.5M1.7M1.6M
Non Current Liabilities Total12.5M525K568K3.3M3.0M4.7M
Other Current Assets115K1.1M825K293K337.0K542.1K
Other Stockholder Equity315.5K36.6M37.3M38.4M44.2M24.8M
Total Liab16.6M938K1.1M4.5M4.0M5.8M
Net Invested Capital(11.9M)15.3M6.2M(3M)(3.5M)(3.3M)
Total Current Assets1.9M16.3M7.3M1.5M1.7M1.6M
Accumulated Other Comprehensive Income(12.5K)(16.3M)17K3M3.5M3.6M
Net Working Capital(2.2M)15.3M6.2M291K334.7K317.9K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.